Our previous work revealed that CXCL12 and CXCL11 promote tumor cell migration with equal potency and further demonstrated that in most tumor cells these migratory responses involve either CXCR7 alone or CXCR7 in combination with another chemokine receptor [6, 15]. The gene discussed is CXCL12; the disease is neoplasm.